RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • SCOPUSKCI등재

        암성통증환자의 통증완하법과 실태에 대한 연구

        백승완(Seong Wan Baik),변병호(Byeung Ho Byeun), 대한통증학회 1998 The Korean Journal of Pain Vol.11 No.2

        N/A Pain is one of the most frequent and disturbing symptom of cancer patients. And almost of cancer patients are afraid of a attacks of pain related to cancer. Caring for the cancer patient can be divided into two phases. The phase of active treatment involves various interventions-surgical, chemical or radiological- that are designed to prolong the patient's life. Terminal care is the period from the end of active treatment until the patient's death. But in the majority of clinical settings, cancer pain is not being managed adequately results from a lack of education about how to treat the cancer pain management in the safest and most effective way during terminal phase,. Althought organic factors represent the most important cause of their pain, it is also important to deal with the patient's psychological reactions and to take account of his or her social and family environment if treatment for chronic cancer pain is to prove adequate. Thus we try to evaluate a kinds of cancer related to pain, degree of pain, effectiveness of drugs, and patient's responses to management, In regard to the satisfaction for pain relief in pain clinics at Pusan National University Hospital(PNUH) are about 70% in patients and 90% in family. Average life expectancy in cancer patients are about 140 days (3 days- 5.7 years). Cancer patients are complained of several discomfortness (above 30 kinds) such as, pain associated with cancer (75%), nausea and vomitting (38%), sleeping disorder (38%), anorexia (38%), dyspnea (32%), constipation (31%), etc. Distributioas of cancer associated with pain are stomach cancer (21%), lung cancer (16%), cervix cancer (10%), anorectal and colon cancer (8.6%), hepatoma (8%), pancreatic cancer (3%). About 1/3 of patients are suffer from incident pain in 3-5 times in a day especially in moving, coughing, and exercise. Methods for drug delivering system before death are transdermal fentanyl patch (42%), intravenous PCA (21%), oral intake of opioid (17%), epidural PCA (14%), etc.

      • SCOPUSKCI등재

        Propofol과 Thiopental의 혼합정주가 혈관통에 미치는 영향

        권재영,백승완,신상욱,김해규,정규섭,변병호 대한마취과학회 1999 Korean Journal of Anesthesiology Vol.36 No.5

        Background : Propofol is a rapidly acting intravenous anesthetic agent used for the induction of anesthesia with a low incidence of side effects. But propofol has a high incidence of pain during intravenous injection, and many methods have been used to minimize the incidence and severity of this pain. The aim of this study was to compare the use of thiopental and lidocaine mixed with propofol for the reduction of pain during the injection of propofol. Methods : Sixty healthy ASA physical status I or II patients scheduled for general anesthesia were randomly divided into three groups. Each patient received mixed propofol solution (normal saline 1 cc, thiopental 0.5 mg/kg, lidocaine 0.5 mg/kg) via 20 G angiocatheter inserted at the antecubital fossa. The assessment of pain was done at the induction of anesthesia and at the recovery room. The severity of pain was classified as none, mild, moderate, and severe. Results : The severity and incidence of pain diminished significantly in the thiopental group and the lidocaine group compared with control group at the induction of anesthesia (p<0.05), and there was no significant difference between the thiopental and the lidocaine group. Recall of pain during intravenous injection at the recovery room has no significant difference among three groups. Conclusions : Mixd administration of thiopental or lidocaine could significantly reduce the severity and incidence of pain for intravenous injection of propofol. (Korean J Anesthesiol 1999; 36: 771∼776)

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼